Article
Intravenous administration of human umbilical cord mesenchymal stromal cells leads to an inflammatory response in the lung
2022-09-26
Abstract excerpt
Mesenchymal stromal cells (MSCs) administered intravenously (IV) have shown efficacy in pre-clinical models of various diseases. This is despite the cells not reaching the site of injury due to entrapment in the lungs. The ability of MSCs to modulate immune responses has been proposed as one of the mechanisms by which these cells provide therapeutic benefits, irrespective of whether they are sourced from bone marr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cbe17079-3967-530f-8276-cc5442efa285
- DOI
- 10.1101/2022.09.26.509547
